Contrast sensitivity in children with and without attention deficit hyperactivity disorder symptoms

Developmental Neuropsychology

Volumn 34, Issue 6, 2009, Pages 663-682

  Bartgis, Jami ^a   Lefler, Elizabeth K ^b   Hartung, Cynthia M ^c   Thomas, David G ^b  

^a National Council on Urban Indian Health   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTRAST SENSITIVITY; FEMALE; HUMAN; MALE; METABOLISM;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CONTRAST SENSITIVITY; DOPAMINE; FEMALE; HUMANS; MALE;

EID: 74949105739     PISSN: 87565641     EISSN: None     Source Type: Journal    
DOI: 10.1080/87565640902964474     Document Type: Article

References (113)

1. Aman, C. J., Roberts, R. J., & Pennington, B. F. (1998). A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: Frontal lobe versus right parietal lobe theories. Developmental Psychology, 34, 956-969.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
3. Amsterdam, J. D., & Newberg, A. B. (2007). A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology, 55, 157-170.
4. Asherson, P., Brookes, K., Franke, B., Chen, W., Gill, M., Ebstein, R. P., et al. (2007). Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. American Journal of Psychiatry, 164, 674-677.
5. Asherson, P., Virdee, V., Curran, S., Ebersole, L., Freeman, B., Craig, I., et al. (1998). Association of study of DSM-IV attention deficit hyperactivity disorder (ADHD) and monoamine pathway genes. American Journal ofMedical Genetics and Neuropsychiatric Genetics, 81, 549.
6. Bannon, M.J., Bunney, E.B., & Roth, R.H. (1981). Mesocortical dopamine neurons: Rapid transmitter turnover compared to other brain catecholamine systems. Brain Research, 218, 376-382.
7. Bannon, M. J., & Roth, R. H. (1983). Pharmacology of mesocortical dopamine neurons. Pharmacological Reviews, 35, 53-68.
8. Barkley, R. A., Grodzinsky, G., & DuPaul, G. J. (1992). Frontal lobe functions in attention deficit disorder with and without hyperactivity. Journal of Abnormal Child Psychology, 20, 163-188.
9. Beiser, M., Dion, R., & Gotowiec, A. (2000). The structure of attention-deficit and hyperactivity symptoms among Native and non-Native elementary school children. Journal of Abnormal Child Psychology, 28, 425-437.
10. Bodis-Wollner, I. (1990). Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends in Neuroscience, 13, 296-302.
11. Bodis-Wollner, I. (1997). Visual electrophysiology in Parkinson's disease: PERG, VEP and visual P300. Clinical Electroencephalography, 28, 143-147.
12. Bodis-Wollner, I., Marx, M. S., Mitra, S., Bobak, P., Mylin, L., & Yahr, M. (1987). Visual dysfunction in Parkinson's disease: Loss in spatiotemporal contrast sensitivity. Brain, 110, 1675-1698.
13. Bradberry, C. W., Karasic, D. H., Deutch, A. Y., & Roth, R. H. (1989). Regionally-specific alterations in mesotelen- cephalic dopamine synthesis in diabetic rats. Journal of Neural Transmission, 78, 221-229.
14. Burn, D. J. (2002). Depression in Parkinson's disease. European Journal of Neurology, 9, 44-54.
15. Cadoret, R. J., & Stewart, M. A. (1991). An adoption study of attention deficit/hyperactivity/aggression and their relationship to adult antisocial personality. Comprehensive Psychiatry, 32, 73-82.
16. Castellanos, F. X., Lau, E., Tayebi, N., Lee, P., Long, R. E., Giedd, J. N., et al. (1998). Lack of association between a doapmine-4 receptor polymorphism and attention deficit hyperactivity disorder: Genetic and brain morphometric analysis. Molecular Psychiatry, 3, 431-434.
17. Castellanos, F. X., Giedd, J. N., Marsh, W. L., Hamburger, S. D., Vaituzis, A. C., Dickstein, D. P., et al. (1996). Quantitative brain magnetic resonance imagining in attention-deficit hyperactivity disorder. Archives of General Psychiatry, 53, 607-616.
18. Chhabildas, N., Pennington, B. F., & Willcutt, E. G. (2001). A comparison of the neuropsychological profiles of the DSM-IV subtypes of ADHD. Journal of Abnormal Child Psychology, 29, 529-540.
19. Collins, P., Wilkinson, L. S., Everitt, B. J., Robbins, T. W., & Roberts, A. C. (2000). The effect of dopamine depletion from the caudate nucleus of the common marmoset (callithrix jacchus) on tests of prefrontal cognitive function. Behavioral Neuroscience, 114, 3-17.
20. Comings, D. E. (1997). Genetic aspects of childhood behavioral disorders. Child Psychiatry and Human Development, 27, 139-150.
21. Comings, D. E., Gonzalez, N., Wu, S., Gade, R., Muhleman, D., Saucier, G., et al. (1999). Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors. American Journal Medical Genetics, 88,358-368.
22. Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., et al. (1995). Association of attention-deficit disorder and the dopamine transporter gene. American Journal of Human Genetics, 56, 993-998.
23. Cornish, K. M., Manly, T., Savage, R., Swanson, J., Morisano, D., Butler, N., et al. (2005). Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Molecular Psychiatry, 10, 686-698.
24. Crucian, G. P., &Okun, M. S. (2003). Visual-spatial ability in Parkinson's disease. Frontiers in Bioscience, 8, 992-997.
25. Curran, S., Mill, J., Tahir, E., Kent, L., Richards, S., Gould, A., et al. (2001). Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Molecular Psychiatry, 6, 425-428.
26. Daly, G., Hawi, Z., Fitzgerald, M., & Gill, M. (1999). Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH, and DRD5 to affected children. Molecular Psychiatry, 4, 192-196.
27. Deutch, A. Y. (1993). Pre-frontal cortical dopamine systems and the elaboration offunctional corticostriatal circuits. Journal of Neural Transmission, 91, 197-221.
28. Diamond, A. (2002). A model for studying the role of dopamine in prefrontal cortex during early development in humans. In C. Nelson & M. Luciana (eds.), Handbook of developmental cognitive neuroscience (pp. 433-472). Cambridge, MA: MIT Press.
29. Diamond, A. (2005). Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): A neuro- biologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity). Development and Psychopathology, 17, 807-825.
30. Diamond, A., & Herzberg, C. (1996). Impaired sensitivity to visual contrast in children treated early and continuously for Phenylketonuria. Brain, 119, 523-538.
31. Diamond, A., Prevor, M. B., Callender, G., & Druin, D. P. (1997). Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monographs of the Society for Research in Child Development, 62 (4, Serial No. 252).
32. DiMaio, S., Grizenko, N., & Joober, R. (2003). Dopamine genes and attention-deficit hyperactivity disorder: A review. Journal of Psychiatry and Neuroscience, 28, 27-38.
33. Djamgoz, M. B. A., Hankins, M. W., Hirano, J., & Archer, S. N. (1997). Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Research, 37, 3509-3529.
34. Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999). Dopamine transporter density in patients with attention deficit hyperactivity disorder. The Lancet, 354, 2132-2133.
35. Edwards, M. C., Gardner, E. S., Chelonis, J. J., Schulz, E. G., Flake, R. A., & Diaz, P. F. (2007). Estimates of the validity and utility of the Conner's Continuous Performance Test in the assessment of inattentive and/or hyperactive-impulsive behaviors in children. Journal of Abnormal Child Psychology, 35, 393-404.
36. Eisenberg, J., Zohar, A., & Mei-Tal, G. (2000). A haplotype relative risk study of the dopamine D4 (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). American Journal of Medical Genetics, 96, 258-261.
37. Elia, J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990). Stimulant drug treatment of hyperactivity. Clinical Pharmacological therapy, 48, 57-66.
38. Fahn, S. (2003). Description of Parkinson's disease as a clinical syndrome. Annuals of the New York Academy of Sciences, 991, 1-14.
39. Fama, R., & Sullivan, E. V. (2002). Motor sequencing in Parkinson's disease. Cortex, 38(5), 753-767.
40. Faraone, S. V., Doyle, A. E., Mick, E., & Biederman, J. (2001). Meta-analysis of the association between the 7-repeat al-lele ofthe dopamine D4 receptor gene and attention deficit hyperactivity disorder. American Journal ofPsychiatry, 158, 1052-1057.
41. Faraone, S. V., & Biederman, J. (1998). Neurobiology of attention deficit hyperactivity disorder. Society ofBiological Psychiatry, 44, 951-958.
42. Faraone, S. V., Biederman, J., Weiffenbach, B., Keith, T., Chu, M. P., Weaver, A., et al. (1999). Dopamine D4 gene 7-re- peat allele and attention deficit hyperactivity disorder. American Journal of Psychiatry, 156, 768-770.
43. Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., et al. (2005). Molecular genetics of attention-deficit hyperactivity disorder. Biological Psychiatry, 57, 1313-1323.
44. Farmer, R. F., & Rucklidge, J. J. (2006). An evaluation ofthe response modulation hypothesis in relation to attention-defi- cit/hyperactivity disorder. Journal of Abnormal Child Psychology, 34, 545-557.
45. Fernstrom, J. D., & Fernstrom, M. H. (1988). Tyrosine availability and dopamine synthesis in the retina. In I. Bodis- Wollner & M. Piccolino (eds.) Dopaminergic mechanisms in vision (pp. 59-70). New York: Liss.
46. Fernstrom, M. H., Volk, E. A., Fernstrom, J. D., & Iuvone, P. M. (1986). Effect of tyrosine administration on dopa accumulation in light- and dark-adapted retinas from normal and diabetic rats. Life Science, 39, 2049-2057.
47. Filipek, P. A., Semrud-Clikeman, M., Steingard, R. J., Renshaw, P. F., Kennedy, D. N., & Biederman, J. (1997). Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls, Neurology, 48, 589-601.
48. Fournet, N., Moreaud, O., Roulin, J. L., Naegele, B., & Pellat, J. (2000). Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication. Neuropsychology, 14, 247-253.
49. Gadow, K. D., & Sprafkin, J. (1994). Child symptom inventory 4 manual. New York: Checkmate Plus.
50. Gadow, K. D., & Sprafkin, J. (1998). Child symptom Inventory 4 screening manual. New York: Checkmate Plus.
51. Geurts, H. M., van der Oord, S., & Crone, E. A. (2006). Hot and cool aspects of cognitive control in children with ADHD: Decision-making and inhibition. Journal of Abnormal Child Psychology, 34, 813-824.
52. Ginsburg, A. P. (1998). Functional Acuity Contrast Test FACT. Chicago, IL: Stereo Optical, Inc.
53. Giros, B., Jabar, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612. Glosser, G. (2001). Neurobehavioral aspects of movement disorders. Neurologic Clinics, 19, 535-551.
54. Grodzinsky, G. M., & Diamond, R. (1992). Frontal lobe functioning in ADHD boys. Developmental Neuropsychology, 8, 427-445.
55. Halperin, J. M., Wolf, L. E., Pascualvaca, D. M., Newcorn, J. H., Healey, J. M., O'Brien, J. D., Morganstein, A., & Young, J. G. (1988). Assessment of attention and impulsivity. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 326-329.
56. Hartung, C. M., Milich, R., Lynam, D. R., & Martin, C. A. (2002). Understanding the relations among gender, disinhibition and disruptive behavior in adolescents. Journal of Abnormal Psychology, 111, 659-664.
57. Hawi, Z., McCarron, M., Kirley, A., Fitzgerald, M., & Gill, M. (2000). No association of the dopamine DRD4 receptor with attention deficit hyperactivity disorder (ADHD) in an Irish sample. American Journal ofMedical Genetics and Neuropsychiatric Genetics, 96, 268-272.
58. Hooks, K., Milich, R., & Lorch, E. P. (1994). Sustained and selective attention in boys with attention deficit hyperactivity disorder. Journal of Clinical Child Psychology, 23, 69-77.
59. Hynd, G. W., Semrud-Clikeman, M., Lorys, A. R., Novey, E. S., & Eliopulos, D. (1990). Brain morphology in developmental dyslexia and attention deficit disorder/ hyperactivity. Archives of Neurology, 47, 919-926.
60. Iaboni, F., Douglas, V. I., & Baker, A. G. (1995). Inhibition in ADHD children. Journal of Abnormal Psychology, 104, 232-240.
61. Iuvone, P. M., Galli, C. L., Garrison-Gund, C. K., & Neff, N. H. (1978). Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons. Science, 202, 901-902.
62. Jonkman, L. M., Kenmer, C., Verbaten, M. N., Koelega, H. S., Camfferman, G., Gaag, R. J., et al. (1997). Effects of methylphenidate on event-related potentials and performance of attention-deficit hyperactivity disorder children in auditory and visual selective attention tasks. Biological Psychiatry, 41, 690-702.
63. Karama, S., Grizenko, N., Sonuga-Barke, E., Doyle, A., Biederman, J., Mbekou, V., et al. (2008). Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry, 8, ArtID 45.
64. Kemppainen, N., Laine, M., Laakso, M. P., Kaasinen, V., Nagren, K., & Vahlberg, T. (2003). Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease. European Journal of Neuroscience, 18, 149-154.
65. Kirley, A., Hawi, Z., Daly, G., McCarron, M., Mullins, C., Millar, N., et al. (2002). Dopaminergic system genes in ADHD. Neuropsychopharmacology, 27, 607-619.
66. Kupersmith, M. J., Shakin, E., Siegel, I. M., & Lieberman, A. (1982). Visual system abnormalities in patients with Parkinson's disease. Archives of Neurology, 39, 284-286.
67. Lahey, B. B., Applegate, B., McBurnett, K., Biederman, J., Greenhill, L., Hynd, G. W., et al. (1994). DSM-IV field trials for ADHD in children and adolescents. American Journal of Psychiatry, 151, 1673-1685.
68. Lorch, E. P., Milich, R., Polley, R. R., van den Broek, P., Baer, S., Hooks, K., et al. (2000). Comprehension of televised stories in attention deficit hyperactivity disordered and normal boys: Effects of diffuse attention. Journal ofAbnormal Psychology, 109, 321-330.
69. Lynn, D. E., Lubke, G., Yang, M., McCracken, J. T., McGough, J. J., Ishii, J., et al. (2005). Temperament and character profiles and the Dopamine D4 receptor gene in ADHD. American Journal of Psychiatry, 162, 906-914.
70. McCann, U. D., Thorne, D., Hall, M., Popp, K., Avery, W., Sing, H. C., et al. (1995). The effects of 1-dihydroxy- phenylalanine on alertness and mood in a-methyl-para-tyrosine-treated healthy humans. Neuropsychopharmacology, 13, 41-52.
71. McGough, J. J., & Barkley, R. A. (2004). Diagnostic controversies in adult attention deficit hyperactivity disorder. American Journal of Psychiatry, 161, 1948-1956.
72. Milich, R., Balentine, A. C. & Lynam, D. R. (2001). ADHD combined type and ADHD predominantly inattentive type are distinct and unrelated disorders. Clinical Psychology: Science and Practice, 8, 463-488
73. Milich, R., Hartung, C. M., Martin, C. A., & Haigler, E. D. (1994). Behavioral disinhibition and underlying processes in adolescents with disruptive behavior disorders. In D. K. Routh (ed.), Disruptive behavior disorders in childhood (pp. 109-138). New York: Plenum Press.
74. Muglia, P., Jain, U., Macciardi, F., & Kennedy, J. L. (2000). Adult attention deficit hyperactivity disorder and the dopa- mine D4 receptor gene. American Journal of Medical Genetics, 96, 273-277.
75. Newcorn, J., Halperin, J., Healey, J., O'Brien, J., Pascualvaca, D., Wolf, L., Morganstein, A., Sharma, V., & Young, J. (1989). Are ADDH and ADHD the same or different? Journal of the American Academy of Child and Adolescent Psychiatry, 28, 734-738.
76. Nguyen-Legros, J. (1988). Functional neuroarchitecture of the retinal. Surgical and Radiologic Anatomy, 10, 137-144.
77. Nieoullon, A. (2002). Dopamine and the regulation of cognition and attention. Progress in Neurobiology, 67, 53-83.
78. Nigg, J. T. (1999). The ADHD response inhibition deficit as measured by the Stop Task: Replication with DSM-IV combined type, extension, and qualification. Journal of Abnormal Child Psychology, 27, 391-400.
79. Nigg, J. T. (2001). Is ADHD a disinhibitory disorder? Psychological Bulletin, 127, 571-598.
80. Nigg, J. T., Stavro, G., Ettenhofer, M., Hambrick, D., Miller, T., & Henderson, J. M. (2005). Executive functions and ADHD in adults: Evidence for selective effects on ADHD symptom domains. Journal ofAbnormal Psychology, 115, 706-717.
81. Oosterlaan, J. S., & Sergeant, J. A. (1998). Effects of reward and response cost on response inhibition in AD/HD, disruptive, anxious, and normal children. Journal of Abnormal Child Psychology, 26, 161-174.
82. Palmer, C. G., Bailey, J. N., Ramsey, C., Cantwell, D., Sinsheimer, J. S., Del'Homme, M., et al. (1999). No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatric Genetics, 9, 157-160.
83. Pavese, N., Andrews, T. C., Brooks, D. J., Ho, A. K., Rosser, R. A., Barker, R. A., et al. (2003). Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A PET study. Brain: A Journal ofNeurology, 126, 1127-1135.
84. Pennington, B. F., Groisser, D., & Welsh, M. C. (1993). Contrasting cognitive deficits in attention deficit hyperactivity disorder versus reading disability. Developmental Psychology, 29, 511-523.
85. Raskin, L. A., Shaywitz, S. E., Shaywitz, B. A., Anderson, G. M., & Cohen, D. J. (1984). Neurochemical correlates of attention deficit disorder. Pediatric Clinics of North America, 31, 387-396.
86. Roman, T., Schmitz, M., Polanczyk, G., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2001). Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. American Journal of Medical Genetics, 105(5), 471-478.
87. Roth, R., & Elsworth, J. (1995). Biochemical pharmacology of midbrain dopamine neurons. In F. Bloom & D. Kupfer (Eds.) Psychopharmacology: The Fourth Generation of Progress (pp. 227-243). New York: Raven Press.
88. Schachar, R., & Tannock, R. (1995). Test of four hypotheses for the comorbidity of attention deficit hyperactivity disorder and conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 639-648.
89. Schachar, R., & Logan, G. D. (1990). Inhibitory control in child psychopathology. Developmental Psychology, 26, 710-720.
90. Schachar, R., Logan, G. D., Robaey, P., Chen, S., Ickowicz, A., & Barr, C. (2007). Restraint and cancellation: Multiple inhibition deficits in attention deficit hyperactivity disorder. Journal ofAbnormal Child Psychology, 35, 229-238.
91. Schachar, R., Mota, V. L., Logan, G. D., Tannock, R., & Klim, P. (2000). Confirmation of an inhibitory control deficit in attention-deficit/ hyperactivity disorder. Journal of Abnormal Child Psychology, 28, 227-236.
92. Schultz, W., Dayan, P., & Montague, P. R. (1997). A neural substrate of prediction and reward. Science, 275,1593-1596.
93. Seeman, P., Guan, H. C., & van Tol, H. H. (1995). Schizophrenia: Elevation of dopamine D4-like sites, using [3H] nemonapride and [125I] epidepride. European Journal of Pharmacology, 286, 3-5.
94. Shue, K. L., & Douglas, V. I. (1992). ADHD and the frontal lobe syndrome. Brain and Cognition, 20, 104-124.
95. Singer, H. S., Szymanski, S., Guiliano, J., Yokoi, F., Semih, D. A., Brasic, J. R., et al. (2002). Elevated intrasynaptic dopamine release in Tourette's syndrome as measured by PET. American Journal of Psychiatry, 159, 1329-1335.
96. Smalley, S. L., Bailey, J. N., Palmer, C. G., Cantwell, D. P., McGough, J. J., Del'Homme, M. A., et al. (1998). Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit. Molecular Psychiatry, 3, 427-430.
97. Solanto, M. V. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactiv- ity disorder. Behavioural Brain Research, 94, 127-152.
98. Spencer, T. J., Biederman, J., Madras, B. K., Dougherty, D. D., Bonab, A. A., Livni, E., et al. (2007). Further evidence of dopamine transporter dysregulation in ADHD: A controlled PET imaging study using altropane. Biological Psychiatry, 62, 1059-1061.
99. Spencer, T. J., Biederman, J., Wilens, T. E., & Farone, S. V. (2002). Overview and neurobiology of attention-deficit/hy- peractivity disorder. Journal of Clinical Psychiatry, 63, 3-9.
100. Stein, M. A., Waldman, I. D., Sarampote, C. S., Seymour, K. E., Robb, A. S., Conlon, C., et al. (2005). Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmocology, 30, 1374-1382.
101. Swanson, J., Sunohara, G. A., Kennedy, J. L., Regino, R., Fineberg, E., Wigal, T., et al. (1998). Association of the dopa- mine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD). Molecular Psychiatry, 3, 38-41.
102. Tannock, R. (1998). Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research. Journal of Child Psychology and Psychiatry, 39(1), 65-99.
103. Tannock, R., Banaschewski, T., & Gold, D. (2006). Color naming deficits and attention-deficit/hyperactivity disorder: A retinal dopaminergic hypothesis. Behavioral and Brain Functions, 2, 4.
104. Todd, R. D., Neuman, R. J., Lobos, E. A., Jong, Y. J., Reich, W., & Health, A. C. (2001). Lack of association of dopamine D4 receptor gene polymorphisms with ADHD subtypes in a population sample of twins. American Journal ofMedical Genetics, 105, 432-438.
105. Tripp, G., & Wickens, J. R. (2008). Dopamine transfer deficit: A neurobiological theory of altered reinforcement mechanisms in ADHD. Journal of Child Psychology and Psychiatry, 49, 691-704.
106. Waldman, I. D., Rowe, D. C., Abramowitz, A., Kozel, S. T., Mohr, J. H., Sherman, S. L., et al. (1998). Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children. American Journal of Human Genetics, 63, 1767-1776.
107. Wechsler, D. (1999). Wechsler Abbreviated Scale of Intelligence. London: Psychological Corporation.
108. Welsh, M. C., Pennington, B. F., Ozonoff, S., Rouse, B., & McCabe, E. R. B. (1990). Neuropsychology of early-treated Phenylketonuria. Child Development, 61, 1697-1713.
109. Wickelgren, I. (1997). Getting the brain's attention. Science, 278, 35-37.
110. Wiederholt, J. L., & Bryant, B. R. (2001). Gray Oral Reading Test-Fourth Edition (GORT-4). Circle Pines, MN: AGS Publishing.
111. Willcutt, E. G., Bidwell, L. C., Hartung, C. M., Barnard, H., Santerre-Lemmon, L., Shanahan, M., et al. (2009). The neuropsychology of ADHD: A comparison of five competing theoretical models. Manuscript in preparation.
112. Willcutt, E. G., Pennington, B. F., Olson, R. K., Chhabildas, N., & Hulslander, J. (2005). Neuropsycho-logical analyses of comorbidity between reading disabilities and attention deficit hyperactivity disorder: In search of the common deficit. Developmental Neuropsychology, 27, 35-78.
113. Wise, R. A., (1996). Neurobiology of addiction. Current Opinion of Neurobiology, 6, 243-251.